Skip to content

Brilliant blue g

Tissueblue (brilliant blue g) is a small molecule pharmaceutical. Brilliant blue g was first approved as Tissueblue on 2019-12-20. It is known to target P2X purinoceptor 7.
Trade Name Tissueblue
Common Name Brilliant blue g
Indication
Drug Class
Brilliant blue g
Get full access now